Clinical trial of boron neutron capture therapy utilizing research reactor for skin malignant tumors

Clinical trial of boron neutron capture therapy utilizing research reactor for skin malignant tumors - Clinical trial of skin malignancy BNCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027541

Enrollment

Registered

2017-08-01

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin malignant tumors

Interventions

BPA is administrated as boron carrier and reactor is utilized as neutron source.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.skin tumors that have relapsed after conventional therapies 2.inoperable skin malignant tumors 3.Without distant metastases 4.PS: less than 2 5.Consent to perform BNCT 6.With the approval of the Medical Ethics Committee 7.Japanese at the age of 16 to 89

Exclusion criteria

Exclusion criteria: 1.with severe complications or double cancers 2.first therapy induced more than Grade 3 side effect 3.medically or socially unacceptable patients

Design outcomes

Primary

Measure	Time frame
tumor response rate and adverse events 6 months after BNCT	—

Countries

Japan

Contacts

Public ContactKawanishi

Kawasaki Medical School Division of Reseach Support

kenkyu-idai@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026